Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jun 1;32(6):784–794. doi: 10.1158/1055-9965.EPI-22-1113

Table 3.

Cox Regression for the associations of Visit 2 sMICA and sMICB levels (continuous variables per 1 relative fluorescent unit (RFU) decrease) with CRC risk in all participants and stratified by sex, race, or diabetes status; ARIC (1990–2015)

N of incident CRC cases Total person-years HR (95% CI)a

sMICA level sMICB level

All participants

312 199,821 0.83 (0.66, 1.05) 1.10 (0.87, 1.39)

Stratified by sex

Male 161 83,933 0.68 (0.49, 0.96) 0.98 (0.72, 1.33)
Female 151 115,888 0.99 (0.71, 1.38) 1.29 (0.90, 1.85)
P-interaction 0.08 0.17

Stratified by race

White 221 153,954 0.84 (0.64, 1.12) 1.20 (0.91, 1.58)
Black 91 45,867 0.80 (0.51, 1.25) 0.87 (0.55, 1.36)
P-interaction 0.97 0.37

Stratified by diabetes status

Yes 59 25,983 0.79 (0.48, 1.31) 0.83 (0.53, 1.31)
No 253 173,838 0.83 (0.64, 1.08) 1.20 (0.91, 1.58)
P-interaction 0.86 0.18
a

Model was adjusted for age, sex, joint terms for race and study center (Black participants from Mississippi; Black participants from any of the other field centers; White participants from Maryland or North Carolina; and White participants from Minnesota), education, BMI, hormone replacement therapy (in women), aspirin use, smoking, pack-years of smoking, diabetes status, and eGFR.